Search results
Cancer-Focused eFFECTOR Therapeutics Shelves Development Of Lung Cancer Candidate After...
Benzinga via Yahoo Finance· 2 months agoThursday, eFFECTOR Therapeutics Inc (NASDAQ:EFTR) released topline results from the primary analysis...